BLOOD-LOSS AND TRANSFUSION REQUIREMENTS IN CYSTIC-FIBROSIS PATIENTS UNDERGOING HEART-LUNG OR LUNG TRANSPLANTATION

被引：3

作者：

PETERSON, KL

DECAMPLI, WM

FEELEY, TW

STARNES, VA

机构：

[1] Department of Anesthesia and Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, CA

来源：

JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA | 1995年 / 9卷 / 01期

关键词：

APROTININ; CYSTIC FIBROSIS; TRANSFUSION REQUIREMENTS; TRANSPLANTATION; HEART OR LUNG;

D O I：

10.1016/S1053-0770(05)80056-4

中图分类号：

R614 [麻醉学];

学科分类号：

100217 ;

摘要：

[No abstract available]

引用

页码：59 / 62

页数：4

共 16 条

[1] APROTININ THERAPY IN CARDIAC OPERATIONS - A REPORT ON USE IN 41 CARDIAC CENTERS IN THE UNITED-KINGDOM [J].

BIDSTRUP, BP ;

HARRISON, J ;

ROYSTON, D ;

TAYLOR, KM ;

TREASURE, T .

ANNALS OF THORACIC SURGERY, 1993, 55 (04) :971-976

[2]

BIDSTRUP BP, 1989, J THORAC CARDIOV SUR, V97, P364

[3]

Bohrer H, 1990, J Cardiothorac Anesth, V4, P222, DOI 10.1016/0888-6296(90)90241-7

[4] BLOOD CONSERVATION TECHNIQUES AND PLATELET-FUNCTION IN CARDIAC-SURGERY [J].

BOLDT, J ;

ZICKMANN, B ;

CZEKE, A ;

HEROLD, C ;

DAPPER, F ;

HEMPELMANN, G .

ANESTHESIOLOGY, 1991, 75 (03) :426-432

[5]

CROPP G, 1984, CYSTIC FIBROSIS F, V25, P17

[6]

DELEVAL MR, 1991, J THORAC CARDIOV SUR, V101, P633

[7] INFLUENCE OF HIGH-DOSE APROTININ TREATMENT ON BLOOD-LOSS AND COAGULATION PATTERNS IN PATIENTS UNDERGOING MYOCARDIAL REVASCULARIZATION [J].

DIETRICH, W ;

SPANNAGL, M ;

JOCHUM, M ;

WENDT, P ;

SCHRAMM, W ;

BARANKAY, A ;

SEBENING, F ;

RICHTER, JA .

ANESTHESIOLOGY, 1990, 73 (06) :1119-1126

[8]

MCCARTHY PM, 1990, J THORAC CARDIOV SUR, V99, P54

[9]

Royston D, 1989, J Cardiothorac Anesth, V3, P80, DOI 10.1016/0888-6296(89)90823-5

[10]

ROYSTON D, 1987, LANCET, V2, P1289

← 1 2 →